Lymphomatoid papulosis in a patient with Crohn's disease treated with infliximab

Inflammatory Bowel Diseases

Volumn 15, Issue 7, 2009, Pages 965-

  Outlaw, William ^a   Fleischer, Alan ^a   Bloomfeld, Richard ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD30 ANTIGEN; INFLIXIMAB; PREDNISONE; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ABDOMINAL PAIN; ADULT; ANOREXIA; ANUS FISTULA; CASE REPORT; CONTROLLED STUDY; CROHN DISEASE; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; LETTER; LYMPHOMATOID PAPULOSIS; MALE; PERIANAL ABSCESS; PRIORITY JOURNAL; RASH; REMISSION; SKIN BIOPSY; SKIN NODULE; WEIGHT REDUCTION; IMMUNE DEFICIENCY; IMMUNOLOGY; SKIN TUMOR;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; LYMPHOMATOID PAPULOSIS; MALE; SKIN NEOPLASMS; YOUNG ADULT;

EID: 69449099722     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20762     Document Type: Letter

References (6)

1. Jones JL, Loftus EV Jr. Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment? Inflamm Bowel Dis. 2007;13: 1299-1307.
2. Slater DN. The new World Health Organization- European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants. Br J Dermatol. 2005;153:874-880.
3. Bekkenk MW, Francoise AM, Geelen J, et al. Primary and secondary cutaneous CD30+ lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95:3653-3661.
4. Nijsten T, Curiel-Lewandrowski C, Kadin ME. Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases. Arch Dermatol. 2004;140:306-312.
5. Gruber R, Sepp NT, Fritsch PO, et al. Prognosis of lymphomatoid papulosis. Oncologist. 2006;11:955-957.
6. Flendrie M, Vissers WH, Creemers MC, et al. Dermatological conditions during TNF-alphablocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther. 2005;7:666-676.